QGEN Upgraded
Morgan Stanley upgrades Qiagen to Overweight and raises price target to $42
Morgan Stanley Upgrades Qiagen to Overweight, Raises Price Target to $42
Morgan Stanley upgrades Qiagen to Overweight and raises price target to $42
Morgan Stanley Upgrades Qiagen to Overweight, Raises Price Target to $42